NAM
ABBV icon

NorthCrest Asset Manangement’s AbbVie ABBV Stock Holding History

NorthCrest Asset Manangement’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$25.1M Buy
100,564
+4,064
+4% +$874K 0.65% 30
2026
Q1 		$20.2M Sell
96,500
-37,641
-28% -$8.35M 0.63% 34
2025
Q4 		$29.5M Buy
134,141
+354
+0.3% +$80.6K 0.66% 34
2025
Q3 		$31.1M Buy
133,787
+1,123
+0.8% +$229K 0.74% 28
2025
Q2 		$25.1M Buy
132,664
+199
+0.2% +$37K 0.67% 38
2025
Q1 		$27.8M Buy
132,465
+836
+0.6% +$163K 0.84% 29
2024
Q4 		$23.4M Buy
131,629
+574
+0.4% +$106K 0.7% 37
2024
Q3 		$25.9M Buy
131,055
+2,127
+2% +$397K 0.78% 32
2024
Q2 		$22.1M Buy
128,928
+3,681
+3% +$610K 0.73% 34
2024
Q1 		$22.8M Sell
125,247
-116
-0.1% -$20K 0.78% 36
2023
Q4 		$19.4M Sell
125,363
-1,167
-0.9% -$170K 0.73% 36
2023
Q3 		$18.9M Buy
126,530
+125,730
+15,716% +$18.5M 0.77% 35
2023
Q2 		$7.48K Buy
+800
New +$117K ﹤0.01% 496
2023
Q1 		– Sell
-92,036
Closed -$14.1M – 487
2022
Q4 		$14.9M Sell
92,036
-3,474
-4% -$533K 0.85% 41
2022
Q3 		$12.8M Buy
95,510
+718
+0.8% +$103K 0.69% 51
2022
Q2 		$14.5M Buy
94,792
+383
+0.4% +$58.5K 0.74% 47
2022
Q1 		$15.3M Buy
94,409
+2,503
+3% +$364K 0.73% 52
2021
Q4 		$12.4M Buy
+91,906
New +$10.9M 0.68% 46

Other funds holding ABBV

Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.94% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

NorthCrest Asset Manangement's ABBV Position: Q2 2026 in Review

NorthCrest Asset Manangement increased its AbbVie (ABBV) stake by 4.2% in Q2 2026, buying an estimated $874K and bringing the position to 100,564 shares worth $25.1M. The position accounts for 0.65% of the portfolio, ranked #30.

NorthCrest Asset Manangement first reported a position in ABBV in Q4 2021 and has held it in 18 quarters since. The position peaked at $31.1M in Q3 2025. 2,236 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • NorthCrest Asset Manangement held 100,564 shares of AbbVie worth $25.1M as of Q2 2026.
  • NorthCrest Asset Manangement bought 4,064 AbbVie shares in Q2 2026, an estimated $874K.
  • AbbVie made up 0.65% of NorthCrest Asset Manangement's portfolio in Q2 2026, its #30 holding.
  • NorthCrest Asset Manangement first reported a position in AbbVie in Q4 2021 and has held it in 18 quarters since.
  • NorthCrest Asset Manangement's AbbVie position peaked at $31.1M in Q3 2025.
  • 2,236 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on NorthCrest Asset Manangement's 13F filing for Q2 2026, filed 15 Jul 2026.